Seborrheic Dermatitis Completed Phase 2 Trials for Pimecrolimus (DB00337)

Also known as: Seborrhea / Seborrhoeic dermatitis / Dermatitis, Seborrheic / Seborrheic eczema / Dermatitis seborrheic / Dermatitis seborrhoeic / Eczema seborrhoeic / Seborrhoea / Seborrheic dermatitis, unspecified / Skin seborrhoeic / Seborrhoeic eczema / Seborrhoeic dermatitis, unspecified / Skin seborrheic

IndicationStatusPhase
DBCOND0036095 (Seborrheic Dermatitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00403559A 4 Week Study of Elidel for the Treatment of Seborrheic DermatitisTreatment